Association between clinical antibiotic resistance and susceptibility ofPseudomonasin the cystic fibrosis lung
Author(s) -
Gunther Jansen,
Niels Mahrt,
Leif Tüeffers,
Camilo Barbosa,
Malte Harjes,
Gernot Adolph,
Anette Friedrichs,
Annegret Krenz-Weinreich,
Philip Rosenstiel,
Hinrich Schulenburg
Publication year - 2016
Publication title -
evolution medicine and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 22
ISSN - 2050-6201
DOI - 10.1093/emph/eow016
Subject(s) - cystic fibrosis , pseudomonas aeruginosa , lung , antibiotics , medicine , antibiotic resistance , pseudomonas , microbiology and biotechnology , bacteria , biology , genetics
Cystic fibrosis patients suffer from chronic lung infections that require long-term antibiotic therapy. Pseudomonas readily evolve resistance, rendering antibiotics ineffective. In vitro experiments suggest that resistant bacteria may be treated by exploiting their collateral sensitivity to other antibiotics. Here, we investigate correlations of sensitivity and resistance profiles of Pseudomonas aeruginosa that naturally adapted to antibiotics in the cystic fibrosis lung.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom